| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Black Diamond Therapeutics, Inc. (BDTX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 39 sells. BDTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 93.6K | $265.3K | - | |
| Dir | 37.1K | $105.3K | - | |
| Dir | 30.6K | $86.6K | - | |
| Dir | 30.6K | $86.6K | - | |
| Dir | 30.6K | $86.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2020 | Versant Venture Capital Vi, L.P.64 | 10% Owner | Sell | 11,348 | $33.14 | $376,126.56 | - | |
| Nov 5, 2020 | Bolzon Bradley J Phd75 | Director, 10% Owner | Sell | 11,348 | $33.14 | $376,126.56 | - | |
| Nov 3, 2020 | Roberts Christopher D. | Chief Scientific Officer | Sale+OE | 2,500 | $31.95 | $79,873.00 | -100% | |
| Nov 2, 2020 | Epstein David M. | See Remarks | Sale+OE | 12,000 | $31.14 | $373,656.39 | -0.8% | |
| Oct 27, 2020 | Bolzon Bradley J Phd75 | Director, 10% Owner | Sell | 8,903 | $33.28 | $296,293.17 | - | |
| Oct 27, 2020 | Versant Venture Capital Vi, L.P.64 | 10% Owner | Sell | 8,903 | $33.28 | $296,293.17 | - | |
| Oct 19, 2020 | Versant Venture Capital Vi, L.P.64 | 10% Owner | Sell | 15,746 | $33.44 | $526,528.85 | - | |
| Oct 19, 2020 | Bolzon Bradley J Phd75 | Director, 10% Owner | Sell | 15,746 | $33.44 | $526,528.85 | - | |
| Oct 14, 2020 | Versant Venture Capital Vi, L.P.64 | 10% Owner | Sell | 17,240 | $33.30 | $574,015.38 | -0.1% | |
| Oct 14, 2020 | Bolzon Bradley J Phd75 | Director, 10% Owner | Sell | 17,240 | $33.30 | $574,015.38 | -0.1% |